Invitae Corporation - stock earnings
Stock symbol NVTA is outdated, potentially delisted? Maybe it is available on other exchange?
NVTA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -206.5 million USD | 120.5 million USD |
| 2022Q4 | -99.8 million USD | 122.5 million USD |
| 2022Q3 | -301.2 million USD | 133.5 million USD |
| 2022Q2 | -2.5 billion USD | 136.6 million USD |
| 2021Q4 | -205.1 million USD | 126.1 million USD |
| 2021Q3 | -198.2 million USD | 114.4 million USD |
| 2021Q2 | 133.8 million USD | 116.3 million USD |
| 2021Q1 | -109.5 million USD | 103.6 million USD |
| 2020Q4 | -234.3 million USD | 100.4 million USD |
NVTA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -3.1 billion USD | 516.3 million USD |
| 2021 | -379.0 million USD | 460.4 million USD |
| 2020 | -602.2 million USD | 279.6 million USD |
| 2019 | -242.0 million USD | 216.8 million USD |
| 2018 | -129.4 million USD | 147.7 million USD |
| 2017 | -123.4 million USD | 68.2 million USD |
NVTA
Price: $0.02
52 week price:
Earnings Per Share: -5.36 USD
P/E Ratio: -0.02
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 8.2 million
Ebitda: -34.6 millionMarket Capitalization: 25.5 million